A Study of CT0596 in Plasma Cell Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Plasma Cell Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Gang An, PhD) · angang@ihcams.ac.cn · 86-022-23909171

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study in Leukemia Patients With Karonudib

Leukemia

Abroad (travel likely)RecruitingPHASE1

Aarhus, Denmark · Copenhagen, Denmark

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Relapsed/Refractory Multiple Myeloma · Plasma Cell Leukemia

Abroad (travel likely)RecruitingPHASE1

Wuhan, China

The Norwegian Immunotherapy in Multiple Myeloma Study

Myeloma Multiple · Plasma Cell Leukemia · AL Amyloidosis

Abroad (travel likely)Recruiting

Arendal, Norway · Ålesund, Norway

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Multiple Myeloma · Plasma Cell Leukemia

Abroad (travel likely)RecruitingPHASE2

Salt Lake City, United States